We have employed the Pi-enhanced 32 P-postlabeling procedure to detect the formation DNA of adducts in the white blood cells (WBC) of B6C3F1 mice treated by i.p. injection with benzene. Treatment twice a day with 440 rag/kg benzene for 1-7 days resulted in the formation of one major (adduct 1) and one minor (adduct 2) DNA adduct in the WBCs of mice. The same DNA adduct pattern was also found in the bone marrow (BM) of benzene treated mice. The relative adduct levels were dependent upon both benzene dose from 100-440 mg/kg and treatment time from 1 to 7 days. The relative adduct levels ranged between 0.11 and 133 adducts in 10 7 nucleotides for WBCs and 0.16-1.21 adducts in 10 7 nucleotides for BM. Following treatment with benzene, the levels of DNA adducts formed in WBCs were significantly correlated with the levels of DNA adducts formed in BM (r 2 = 0.97, P <0.001). Our results suggest that measurement of DNA adducts in WBCs may be an indicator of DNA adduct formation in BM following BZ exposure.
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Benzene (BZ*) is widely used in the chemical industry and as a fuel additive. It is also found in automobile exhaust and cigarette smoke (1). Thus, human exposure to BZ occurs from both industrial and environmental sources (1-3). It is also well established that exposure to BZ is hematotoxic and leukemogenic in humans (4, 5) . Animal experiments indicate that acute exposure to BZ results in toxic effects to the hematopoietic system (6-9) and chronic exposure is carcinogenic in both rats and mice (10, 11) .
After absorption, BZ is initially metabolized in the liver by cytochrome 2E1 (12, 13) . The principal metabolites are phenol, hydroquinone (HQ) and catechol (CAT) (14, 15) . Hydroquinone and CAT accumulate in the bone marrow, where they are further activated to exert their myelotoxic effects (16, 17) . Although the enzymatic mechanisms responsible for this activation are not yet fully understood; substantial evidence for the involvement of peroxidase enzymes (18, 19) and prostaglandin H synthase (20) in this process has been presented.
In in vitro studies we have reported that cellular activation of HQ, CAT and 1,2,4-benzenetriol (BT) leads to the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow cells. The extent of DNA modification showed a good correlation with both cytotoxicity and peroxidase activity in the treated cells (21) (22) (23) .
The 32 P-postlabeling procedure has been demonstrated to be a very sensitive method for the detection of carcinogen-DNA adducts (24, 25) . One of the applications of this procedure has been to compare the levels of DNA adducts formed in tissues with those formed in the white blood cells (WBC) following treatment with various carcinogens (26) (27) (28) (29) . In general, the results have demonstrated a good correlation between adducts formed in WBCs with those formed in various tissues. These studies indicate that measurement of DNA adducts in WBCs can be used as a molecular marker of exposure to occupational and environmental agents.
Recently, we have demonstrated the formation of DNA adducts in the bone marrow (BM) of B6C3F1 mice, treated twice a day with benzene (30) . The purpose of the present study was to determine if treatment of B6C3F1 mice with BZ results in the formation of DNA adducts in WBCs and to analyze the relationship between adduct formation in WBCs with that in BM.
Benzene (99.9% pure) was purchased from Aldrich Chemical Co. (Milwaukee, WI). The other chemicals and reagents used were of highest purity and analytical grade available. Male B6C3F1 mice, 6-8 weeks old (weighing 30-35 g), were purchased from Simonsen Laboratories (Gilroy, CA) and housed in metal cages for 1 week before treatment. The animals were fed standard Purina Rat Chow 50/2 and were given free access to water.
BZ was dissolved in corn oil (100-440 mg/kg) and was administered twice a day by i.p. injection at 8 h intervals for 1-7 days. Each treatment group consisted of 5-7 mice. Controls received corn oil only. Following the scheduled treatment, the animals were anesthetized and blood was drawn by cardiac puncture. Four to five milliliters of pooled, heparinized blood were mixed with 0.5 ml of 0.5 M ammonium chloride and centrifuged at 3000 g for 20 min. The supernatant containing the lysed red blood cells was discarded and the procedure was repeated. The resulting pellet was kept frozen until the DNA was isolated. After the blood was drawn the mice were killed by cervical dislocation. Both femurs were removed and the marrow was flushed from the femurs into RPMI 1640 medium supplemented With 10% fetal calf serum. The samples were washed; centrifuged at 1000 g for 25 min and stored at -70°C.
The DNA was isolated and the samples were 32 P-postlabeled as previously described (21- In the buffers D o and D, die plates were developed from the bottom to the top, whereas in the buffers D 2 and D 3 they were developed at a right angle to the previous direction. The adducts were located by autoradiography using Kodak XAR-5 film and a DuPont Chronex Lightning Plus intensifying screen. The areas corresponding to adducts were scraped into scintillation vials containing 5 ml of scintillation cocktail (Safety Solve, Research Products Inc., Mount Prospect, IL) and the radioactivity was determined by scintillation counting. The relative adduct levels were calculated as previously described (21) (22) (23) .
B6C3F1 mice were treated twice a day with 440 mg/kg of BZ for 3 days. DNA was isolated from WBCs and BM and analyzed by 32 P-postlabeling. Figure 1A shows the autoradiogram from the postlabeling analysis of the DNA isolated from WBCs. One principal (#1, 91.4%) and one minor adduct (#2, 8.6%) were detected. The relative adduct level produced by this treatment was 0.73 ± 0.12X10" 7 . Figure IB shows the postlabeling analysis of the DNA isolated from BM. An adduct pattern similar to that in WBCs was found in these samples. The relative adduct level was 0.66 ± 0.08 X10~7. No adducts were detected in the vehicle treated control animals (data not shown).
B6C3F1 mice were treated with either 100, 250 or 440 mg/ kg BZ for 7 days. The levels of DNA adducts produced by these treatments in the WBCs and BM were determined. Similar levels of DNA adducts were found in both sample groups ( Figure 2A ). The levels of adducts were significantly correlated with the BZ dose (r 2 = 0.95, P <0.001). In one set of experiments, the effect of treatment time on DNA adduct formation was examined. For these studies mice were treated with 440 mg/kg of BZ twice a day for 1-7 days. Once again similar levels of DNA adducts were observed in both WBCs and BM ( Figure 2B ) which were significantly correlated with the treatment time (r 2 = 0.97, P <0.001). These studies have demonstrated that the administration of BZ twice a day results in a dose and time dependent formation of DNA adducts in both WBCs and BM. The DNA adducts formed in these different tissues were the same and there was a highly significant correlation (r 2 = 0.97, P <0.001) between the levels of DNA adducts formed in the BM and the WBCs. The formation of DNA adducts in both WBCs and BM was nearly linear. Similar observations to these have been made in other investigations (26) (27) (28) (29) 31 ). Given the presence of shortlived cells within the WBC population (27), we interpret our results to indicate that under these lengths of treatment (1-7 days), there is not sufficient loss of these cells to influence the dose-response curve.
In previous studies we have investigated the formation of DNA adducts in the BM of mice administered BZ (30) . Our studies indicated that the formation of DNA adducts was dependent upon the treatment schedule with BZ. Once a day administration of BZ did not lead to detectable adduct formation which is similar to that reported by Reddy et al. (32, 33) . In contrast, as in these studies, when BZ was administered twice a day, DNA adducts were readily detectable. These results suggest that with twice a day administration of BZ, metabolites accumulate which are subsequently activated to form DNA adducts. Co-chromatography and rechromatography experiments have demonstrated that adducts 1 and 2 are formed by HQ and BT respectively (30) . These results imply that HQ is the principal metabolite of BZ leading to DNA adduct formation both in WBCs and BM.
We found a highly significant correlation between the levels of DNA adducts formed in the BM and in the WBCs of B6C3F1 mice treated with BZ. These results with BZ are similar to those reported for a variety of polycyclic and other compounds (26) (27) (28) (29) 31 )-Although these results would indicate that measurement of DNA adducts in WBCs may be useful as a dosimeter of BZ exposure, they have to be considered together with our observation that no DNA adducts were detected after once a day administration of BZ (30) . Comparison of the dose dependent formation of DNA adducts in WBCs and BM with that of the loss in BM cellularity (30) showed an extremely good correlation (r 2 = 0.99, P <0.001) between these endpoints. These data taken together demonstrate that in mice the formation of DNA adducts in WBCs is a better indicator of a biological effect than a molecular dosimeter of BZ exposure.
The long term goal of these studies is to determine if BZ-DNA adducts can be detected in populations occupationally exposed to BZ. Recently Rothman et al. (34) have reported increased frequencies of glycophorin A mutations in a BZexposed group of workers. The mean time weighted average BZ exposure was 72 p.p.m. which is equivalent to 229.9 mg/ m 3 . If we assume a daily inhalation rate of 1 m 3 /h, then over an 8 h period an individual would inhale -1.84 g of BZ. In our studies, BZ-DNA adducts were detected after treatment of mice with 440 mg/kg of BZ twice a day for 1 day. An equivalent dose for a 70 kg individual would require 61.6 g of BZ in a single day. Comparison of the estimated amount of BZ received by occupational exposure (1.8 g) with our calculated equivalent dose (61.6 g) reveals that the exposure dose is -3% of the calculated equivalent dose. This analysis suggests that we may be able to detect DNA adducts in workers occupationally exposed daily to high levels of BZ.
